CryoLife, Inc. (NYSE:CRY) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $22.15 and last traded at $22.15, with a volume of 154,571 shares. The stock had previously closed at $21.50.

Several brokerages recently issued reports on CRY. BidaskClub lowered shares of CryoLife from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Zacks Investment Research raised shares of CryoLife from a “sell” rating to a “hold” rating in a research note on Monday, August 14th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $22.00.

The company has a market cap of $741.67 million, a price-to-earnings ratio of 67.197 and a beta of 0.97. The stock has a 50-day moving average of $19.19 and a 200 day moving average of $18.05.

CryoLife (NYSE:CRY) last issued its quarterly earnings data on Monday, July 24th. The medical equipment provider reported $0.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.10 by $0.02. The business had revenue of $47.80 million for the quarter, compared to the consensus estimate of $47.02 million. CryoLife had a net margin of 6.16% and a return on equity of 7.41%. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 EPS. On average, equities research analysts predict that CryoLife, Inc. will post $0.43 EPS for the current year.

In other news, VP Amy Horton sold 9,577 shares of the business’s stock in a transaction on Tuesday, June 27th. The shares were sold at an average price of $20.00, for a total transaction of $191,540.00. Following the sale, the vice president now owns 112,282 shares in the company, valued at approximately $2,245,640. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 6.00% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. State of Alaska Department of Revenue boosted its holdings in shares of CryoLife by 80.8% during the 2nd quarter. State of Alaska Department of Revenue now owns 5,387 shares of the medical equipment provider’s stock valued at $107,000 after buying an additional 2,407 shares in the last quarter. First Mercantile Trust Co. boosted its holdings in shares of CryoLife by 5.6% during the 2nd quarter. First Mercantile Trust Co. now owns 5,448 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 291 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its holdings in shares of CryoLife by 3.2% during the 1st quarter. Municipal Employees Retirement System of Michigan now owns 6,150 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 190 shares in the last quarter. Mason Street Advisors LLC boosted its holdings in shares of CryoLife by 7.4% during the 1st quarter. Mason Street Advisors LLC now owns 6,324 shares of the medical equipment provider’s stock valued at $105,000 after buying an additional 438 shares in the last quarter. Finally, Creative Planning boosted its holdings in shares of CryoLife by 3.0% during the 2nd quarter. Creative Planning now owns 6,806 shares of the medical equipment provider’s stock valued at $136,000 after buying an additional 200 shares in the last quarter. Hedge funds and other institutional investors own 68.85% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “CryoLife, Inc. (CRY) Hits New 52-Week High at $22.15” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/09/05/cryolife-inc-cry-hits-new-52-week-high-at-22-15.html.

About CryoLife

CryoLife, Inc (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.